Literature DB >> 35418402

Thérapies endocriniennes contre les cancers du sein et de la prostate: Éléments essentiels en première ligne.

Geneviève Chaput1, Nureen Sumar2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35418402      PMCID： PMC9007135          DOI： 10.46747/cfp.6804e120

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  21 in total

Review 1.  A 2009 update on the treatment of patients with hormone receptor-positive breast cancer.

Authors:  Susan J Cleator; Eliyaz Ahamed; R Charles Coombes; Carlo Palmieri
Journal:  Clin Breast Cancer       Date:  2009-06       Impact factor: 3.225

2.  NCCN clinical practice guidelines in oncology: prostate cancer.

Authors:  James Mohler; Robert R Bahnson; Barry Boston; J Erik Busby; Anthony D'Amico; James A Eastham; Charles A Enke; Daniel George; Eric Mark Horwitz; Robert P Huben; Philip Kantoff; Mark Kawachi; Michael Kuettel; Paul H Lange; Gary Macvicar; Elizabeth R Plimack; Julio M Pow-Sang; Mack Roach; Eric Rohren; Bruce J Roth; Dennis C Shrieve; Matthew R Smith; Sandy Srinivas; Przemyslaw Twardowski; Patrick C Walsh
Journal:  J Natl Compr Canc Netw       Date:  2010-02       Impact factor: 11.908

3.  Endocrine therapy for breast cancer in the primary care setting.

Authors:  A Awan; K Esfahani
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

4.  Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies.

Authors:  Andrea Kokorovic; Alan I So; Hosam Serag; Christopher French; Robert J Hamilton; Jason P Izard; Jasmir G Nayak; Fréderic Pouliot; Fred Saad; Bobby Shayegan; Armen Aprikian; Ricardo A Rendon
Journal:  Can Urol Assoc J       Date:  2021-06       Impact factor: 1.862

Review 5.  Androgen deprivation therapy: indications, methods of utilization, side effects and their management.

Authors:  Diana E Magee; Rajiv K Singal
Journal:  Can J Urol       Date:  2020-02       Impact factor: 1.344

Review 6.  Current practice in patients with differentiated thyroid cancer.

Authors:  Martin Schlumberger; Sophie Leboulleux
Journal:  Nat Rev Endocrinol       Date:  2020-12-18       Impact factor: 43.330

7.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

Authors: 
Journal:  Lancet       Date:  2005 May 14-20       Impact factor: 79.321

8.  Medication adherence among patients with advanced prostate cancer using oral therapies.

Authors:  Dominic Pilon; Joyce LaMori; Carmine Rossi; Mike Durkin; Isabelle Ghelerter; Xuehua Ke; Marie-Hélène Lafeuille; Lorie Ellis; Patrick Lefebvre
Journal:  Future Oncol       Date:  2021-11-03       Impact factor: 3.404

Review 9.  Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association.

Authors:  Tochi M Okwuosa; Alicia Morgans; June-Wha Rhee; Kerryn W Reding; Sally Maliski; Juan-Carlos Plana; Annabelle Santos Volgman; Kendall F Moseley; Charles B Porter; Roohi Ismail-Khan
Journal:  Circ Genom Precis Med       Date:  2021-04-26

Review 10.  Hormonal Therapy for Prostate Cancer.

Authors:  Kunal Desai; Jeffrey M McManus; Nima Sharifi
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 19.871
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.